Gates Cambridge to take part in Hay Festival panel on vaccine policy
Four Gates Cambridge Scholars and Alumni will take part in a panel on vaccination and the future of global health at this year's Hay Festival next week.
Emma Glennon, Samir Ali Khan, Julia Fan Li and Dan Storisteanu will speak at the online event on 27th May which will be chaired by Dan Davis, Professor of Immunology at the University of Manchester and author of The Beautiful Cure.
Emma Glennon , who is doing a PhD in Veterinary Science, will speak about her work as an infectious disease epidemiologist, examining why new diseases emerge. Emma's research lies at the intersections of ecology, data science and the social and economic determinants of disease and she has worked on epidemiological research and outbreak response around the world, including in the UK, India, Australia, and the Democratic Republic of the Congo. In her talk, she will focus on how technology in an unequal world can counteract or contribute to the spread of disease.
Samir Ali Khan  did his PhD in Pharmacology. Samir is co-founder of Lighthouse Innovations, an Oxford-based innovation and access strategy house advising health start-ups and entrepreneurs on market access, pricing and payer value strategy within and beyond the NHS in the UK. He has previously advised top 10 FTSE global life sciences and healthcare companies and more than 50 start-ups on market access strategy for drugs, vaccines, diagnostics and AI. Samir is also a co-inventor of a vaccine candidate for Hepatitis E in India and drug targets in neurological and cardiovascular diseases in the UK. He will talk about the challenges in innovation and the role of collaboration in accelerating vaccine development. He will also discuss the role of pricing innovation in the future impact of and equitable access to vaccines.
Dan Storisteanu  did his PhD in Medicine. A Research Fellow at Darwin College and Visiting Scholar at the Laboratory of Viral Zoonotics, he is co-founder of Simprints, a leading biometric identification start-up, where he focuses on research, testing and deployment of a biometric system for global health applications. He also works with another Cambridge start-up, DIOSynVax, where he supports efforts to develop Ebola, influenza and COVID vaccines. He will talk about his work in COVID-19 vaccine development and also about Simprints' role in last mile vaccine distribution.
Julia Fan Li  did her PhD in Engineering and is CEO of Micrographia Bio, a biotechnology company operating at the intersection of machine learning and drug discovery. A Gates Cambridge Trustee, Julia was previously Director of the Global Health Investment Fund – a social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low-income countries. She will talk about what we can learn from historic business models which aim to provide treatments and vaccines more equitably across the world and about what we can do to prevent future pandemics, for example, greater investment in databases, manufacturing capacity and research.